cepia

Clinical Epidemiology and Ageing

Our publications

All our original articles and reviews published in international peer-reviewed journals.

2019

  1. Allaire M, Rekik S, Layese R, Mumana A, Guyot E, Nkontchou G, Bourcier V, Grando V, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Audureau E, Seror O, Nault J-C. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Dig Liver Dis. 2019;51(1):86-94.
  2. Bouillanne O, Melchior J-C, Faure C, Paul M, Canoui-Poitrine F, Boirie Y, Chevenne D, Forasassi C, Guery E, Herbaud S, Le Corvoisier P, Neveux N, Nivet-Antoine V, Astier A, Raynaud-Simon A, Walrand S, Cynober L, Aussel C. Impact of 3-week citrulline supplementation on postprandial protein metabolism in malnourished older patients: The Ciproage randomized controlled trial. Clin Nutr. 2019;38(2):564-574.
  3. Gelu-Simeon M, Lewin M, Ostos M, Bayan T, Delgado MBeso, Teicher E, Layese R, Roudot-Thoraval F, Fontaine H, Sobesky R, Salmon-Céron D, Samuel D, Seror O, Nahon P, Meyer L, Duclos-Vallée J-C. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver Int. 2019;39(1):136-146.
  4. Petrucciani N, Brunetti F, de'Angelis N. Urinary Tract Infection and Vaginal Purulent Flow in a Patient With Recurrent Sigmoiditis. Gastroenterology. 2019;156(1):e5-e7.
  5. Brichler S, Nahon P, Zoulim F, Layese R, Bourcier V, Audureau E, Sutton A, Letouze E, Cagnot C, Marcellin P, Guyader D, Roulot D, Pol S, De Lédinghen V, Zarski J-P, Calès P, Tran A, Péron J-M, Mallat A, Riachi G, Grangé J-D, Blanc J-F, Bacq Y, Ouzan D, Bronowicki J-P, Mathurin P, Larrey D, Alric L, Attali P, Serfaty L, Pilette C, Bourlière M, Thabut D, Silvain C, Wartelle C, Zucman D, Christidis C, Roudot-Thoraval F, Ganne-Carrié N. Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort. J Viral Hepat. 2019;26(3):384-396.
  6. Contou D, Canoui-Poitrine F, Coudroy R, Préau S, Cour M, Barbier F, Terzi N, Schnell G, Galbois A, Zafrani L, Zuber B, Ehrmann S, Gelisse E, Colling D, Schmidt M, Jaber S, Conia A, Sonneville R, Colin G, Guérin L, Roux D, Jochmans S, Kentish-Barnes N, Audureau E, Layese R, Alves A, Ouedraogo R, Brun-Buisson C, Dessap AMekontso, de Prost N. Long-term Quality of Life in Adult Patients Surviving Purpura Fulminans: An Exposed-Unexposed Multicenter Cohort Study. Clin Infect Dis. 2019;69(2):332-340.
  7. Pamoukdjian F, Liuu E, Caillet P, Herbaud S, Gisselbrecht M, Poisson J, Boudou-Rouquette P, Zelek L, Paillaud E. How to Optimize Cancer Treatment in Older Patients: An Overview of Available Geriatric Tools. Am J Clin Oncol. 2019;42(2):109-116.
  8. Zehou O, Ferkal S, Brugières P, Barbarot S, Bastuji-Garin S, Combemale P, Valeyrie-Allanore L, Sbidian E, Wolkenstein P. Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial. J Invest Dermatol. 2019;139(3):718-720.
  9. Belkacemi Y, Colson-Durand L, Fayolle-Campana M, Pons P, Rialland A, Bastuji-Garin S, Hoang QNguyen, Lerouge D, Jaffré F, Bollet M, Azria D. A Wake-Up Call for Routine Morbidity and Mortality Review Meeting Procedures as Part of a Quality Governance Programs in Radiation Therapy Departments: Results of the PROUST Survey. Pract Radiat Oncol. 2019;9(2):108-114.
  10. Thuleau A, Gilbert C, Bauër P, Alran S, Fourchotte V, Guillot E, Vincent-Salomon A, Kerihuel J-C, Dugay J, Semetey V, Kriegel I, Fromantin I. A New Transcutaneous Method for Breast Cancer Detection with Dogs. Oncology. 2019;96(2):110-113.

2018

  1. Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne P-L, Faroux R, F Akouz K, F Hajbi E, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, Francois E, Bedenne L. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results. Ann Oncol. 2018;29(1):133-138.
  2. Petrucciani N, Debs T, Nigri G, Giannini G, Sborlini E, Kassir R, Ben Amor I, Iannelli A, Valabrega S, D'Angelo F, Gugenheim J, Ramacciato G. Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review. HPB (Oxford). 2018;20(1):3-10.
  3. de'Angelis N, Abdalla S, Bianchi G, Memeo R, Charpy C, Petrucciani N, Sobhani I, Brunetti F. Robotic Versus Laparoscopic Colorectal Cancer Surgery in Elderly Patients: A Propensity Score Match Analysis. J Laparoendosc Adv Surg Tech A. 2018;28(11):1334-1345.
  4. Nigri G, Petrucciani N, Debs T, Mangogna LMaria, Crovetto A, Moschetta G, Persechino R, Aurello P, Ramacciato G. Treatment options for PNET liver metastases: a systematic review. World J Surg Oncol. 2018;16(1):142.
  5. Nigri G, Petrucciani N, Pinna ADaniele, Ravaioli M, Jovine E, Minni F, Grazi GLuca, Chirletti P, Balzano G, Ferla F, De Carlis L, Tisone G, Napoli N, Boggi U, Ramacciato G. Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units. Int J Surg. 2018;55:103-109.
  6. Aparicio T, Bouché O, Francois E, Retornaz F, Barbier E, Taieb J, Kirscher S, Etienne P-L, Faroux R, F Akouz K, F Hajbi E, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Bedenne L, Paillaud E. Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer. Eur J Cancer. 2018;97:16-24.
  7. Fancellu A, Petrucciani N, Melis M, Porcu A, Feo CF, Zorcolo L, Nigri G. Usefulness of Infra-hepatic Inferior Vena Cava Clamping During Liver Resection: a Meta-analysis of Randomized Controlled Trials. J Gastrointest Surg. 2018;22(5):941-951.
  8. Petrucciani N, Martínez-Pérez A, Bianchi G, Memeo R, Brunetti F, Angelis NDe'. The use of laparoscopy for locally advanced rectal cancer. Minerva Chir. 2018;73(1):77-92.
  9. Ramacciato G, Petrucciani N, Nigri G. Open vs Minimally Invasive Approach in Pancreatic Surgery: Where Are We?. J Am Coll Surg. 2018;226(2):203-204.
  10. Vergnenègre A, Chouaid C. Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC). Expert Rev Pharmacoecon Outcomes Res. 2018;18(5):519-528.
  11. Bylicki O, Paleiron N, Rousseau-Bussac G, Chouaid C. New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab. Onco Targets Ther. 2018;11:4051-4064.
  12. Saboundji K, Auliac J-B, Perol M, François G, Janicot H, Marcq M, Dubos-Arvis C, Renault A, Guisier F, Odier L, Gervais R, Chouaid C. Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors. Target Oncol. 2018;13(4):501-507.
  13. Naccache J-M, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, Cadranel J. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis. 2018;10(6):3829-3844.
  14. Garassino MChiara, Cho B-C, Kim J-H, Mazières J, Vansteenkiste J, Lena H, Jaime JCorral, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Huang Y, Wadsworth C, Dennis PA, Rizvi NA. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. Lancet Oncol. 2018;19(4):521-536.
  15. Picchi H, Mateus C, Chouaid C, Besse B, Marabelle A, Michot JM, Champiat S, Voisin AL, Lambotte O. Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment. Clin Microbiol Infect. 2018;24(3):216-218.
  16. Gauvain C, Vauléon E, Chouaid C, Le Rhun E, Jabot L, Scherpereel A, Vinas F, Cortot ABenjamin, Monnet I. Intracerebral efficacy and tolerance of nivolumab in non-small-cell lung cancer patients with brain metastases. Lung Cancer. 2018;116:62-66.
  17. Babey H, Quere G, Descourt R, Le Calloch R, Lanfranco L, Nousbaum J-B, Cornec D, Tison A, Chouaid C. Immune-checkpoint inhibitors to treat cancers in specific immunocompromised populations: a critical review. Expert Rev Anticancer Ther. 2018;18(10):981-989.
  18. la Martire G, Robin C, Oubaya N, Lepeule R, Beckerich F, Leclerc M, Barhoumi W, Toma A, Pautas C, Maury S, Akrout W, Cordonnier-Jourdin C, Fihman V, Venditti M, Cordonnier C. De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome. Eur J Clin Microbiol Infect Dis. 2018;37(10):1931-1940.
  19. Gauthier M, Canoui-Poitrine F, Guery E, Desvaux D, Hue S, Canaud G, Stehlé T, Lang P, Kofman T, Grimbert P, Matignon M. Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey. Nephrol Dial Transplant. 2018;33(4):709-716.
  20. Serris A, Amoura Z, Canoui-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg J-E, Godeau B, Michel M. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults. Am J Hematol. 2018;93(3):424-429.
  21. Lemogne C, Turinici M, Panjo H, Ngo C, Canoui-Poitrine F, Chauvet-Gelinier J-C, Limosin F, Consoli SM, Goldberg M, Zins M, Ringa V. Personality and breast cancer screening in women of the GAZEL cohort study. Cancer Med. 2018;7(2):515-524.
  22. Frasca M, Soubeyran P, Bellera C, Rainfray M, Leffondre K, Mathoulin-Pélissier S. Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer. Eur J Cancer. 2018;90:10-18.
  23. Contou D, Sonneville R, Canoui-Poitrine F, Colin G, Coudroy R, Pène F, Tadié J-M, Cour M, Béduneau G, Marchalot A, Guérin L, Jochmans S, Ehrmann S, Terzi N, Préau S, Barbier F, Schnell G, Roux D, Leroy O, Pichereau C, Gelisse E, Zafrani L, Layese R, Brun-Buisson C, Dessap AMekontso, de Prost N. Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study. Intensive Care Med. 2018;44(9):1502-1511.
  24. Hanon O, Vidal J-S, Lehmann S, Bombois S, Allinquant B, Tréluyer J-M, Gelé P, Delmaire C, Blanc F, Mangin J-F, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P-H, Godefroy O, Dantoine T, Camus V, Belmin J, Vandel P, Novella J-L, Duron E, Rigaud A-S, Schraen-Maschke S, Gabelle A. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers. Alzheimers Dement. 2018;14(7):858-868.
  25. Hentati H, Salloum C, Caillet P, Lahat E, Disabato M, Levesque E, Compagnon P, Lim C, Azoulay D. Risk Factors for Mortality and Morbidity in Elderly Patients Presenting with Digestive Surgical Emergencies. World J Surg. 2018;42(7):1988-1996.
  26. Sobhani I, Itti E, Luciani A, Baumgaertner I, Layese R, André T, Ducreux M, Gornet J-M, Goujon G, Aparicio T, Taieb J, Bachet J-B, Hemery F, Retbi A, Mons M, Flicoteaux R, Rhein B, Baron S, Cherrak I, Rufat P, Le Corvoisier P, de'Angelis N, Natella P-A, Maoulida H, Tournigand C, I Zaleski D, Bastuji-Garin S. Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial. Ann Oncol. 2018;29(4):931-937.
  27. Magny E, Le Petitcorps H, Pociumban M, Bouksani-Kacher Z, Pautas É, Belmin J, Bastuji-Garin S, Lafuente-Lafuente C. Predisposing and precipitating factors for delirium in community-dwelling older adults admitted to hospital with this condition: A prospective case series. PLoS One. 2018;13(2):e0193034.
  28. Brenaut E, Bastuji-Garin S. [Notions of epidemiology of value in dermatology]. Ann Dermatol Venereol. 2018;145(2):129-140.
  29. Audureau E, Simon-Deckers A, Franco-Montoya M-L, Annangi B, Kermanizadeh A, Boczkowski J, Lanone S. Substantial modification of the gene expression profile following exposure of macrophages to welding-related nanoparticles. Sci Rep. 2018;8(1):8554.
  30. Bocahut N, Audureau E, Poignard A, Delambre J, Queinnec S, Lachaniette C-HFlouzat, Allain J. Incidence and impact of implant subsidence after stand-alone lateral lumbar interbody fusion. Orthop Traumatol Surg Res. 2018;104(3):405-410.
  31. Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim S-W, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim D-W, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB. Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2018;13(4):576-584.
  32. Cacoub P, Nahon P, Layese R, Blaise L, Desbois AClaire, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Zucman D, Di Martino V, Bagnis CIsnard, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients. Am Heart J. 2018;198:4-17.
  33. Allaire M, Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouze E, Audureau E, Roudot-Thoraval F. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology. 2018;68(4):1245-1259.
  34. Teiger E, Thambo J-B, Defaye P, Hermida J-S, Abbey S, Klug D, Juliard J-M, Pasquie J-L, Rioufol G, Lepillier A, Elbaz M, Horvilleur J, Brenot P, Pierre B, Le Corvoisier P. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events. Circ Cardiovasc Interv. 2018;11(3):e005841.
  35. Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Roudot-Thoraval F, Audureau E. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. Gastroenterology. 2018;155(5):1436-1450.e6.
  36. Blondiaux E, Chougar L, Gelot A, Valence S, Audureau E, le Pointe HDucou, Jouannic J-M, Dhombres F, Garel C. Developmental patterns of fetal fat and corresponding signal on T1-weighted magnetic resonance imaging. Pediatr Radiol. 2018;48(3):317-324.
  37. Schlemmer F, Boyer L, Soumagne T, Ridoux A, Chouaid C, Maitre B, Lanone S, Adnot S, Audureau E, Boczkowski J. Beclin1 circulating levels and accelerated aging markers in COPD. Cell Death Dis. 2018;9(2):156.
  38. Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, Zouaoui S, Guyotat J, Le Reste P-J, Faillot T, Litre F, Desse N, Petit A, Emery E, Lechapt-Zalcman E, Peltier J, Duntze J, Dezamis E, Voirin J, Menei P, Caire F, Hieu PDam, Barat J-L, Langlois O, Vignes J-R, Fabbro-Peray P, Riondel A, Sorbets E, Zanello M, Roux A, Carpentier A, Bauchet L, Pallud J. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. J Neurooncol. 2018;136(3):565-576.
  39. Bassez G, Audureau E, Hogrel J-Y, Arrouasse R, Baghdoyan S, Bhugaloo H, Gourlay-Chu M-L, Le Corvoisier P, Peschanski M. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. Brain. 2018;141(10):2855-2865.
  40. Ridouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux J-F. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis. J Cardiovasc Magn Reson. 2018;20(1):58.
  41. Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouze E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study. Gastroenterology. 2018;155(2):431-442.e10.
  42. Winter A, Féray C, Audureau E, Azoulay D, Antoine C, Daurès J-P, Landais P. A Donor Quality Index for liver transplantation: development, internal and external validation. Sci Rep. 2018;8(1):9871.
  43. Boyer L, Bastuji-Garin S, Chouaid C, Housset B, Le Corvoisier P, Derumeaux G, Boczkowski J, Maitre B, Adnot S, Audureau E. Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach. Sci Rep. 2018;8(1):8569.
  44. Wendum D, Layese R, Ganne-Carrié N, Bourcier V, Merabtene F, Cagnot C, Sauce E, Barget N, Bedossa P, Terris B, Selves J, Bioulac-Sage P, Sturm N, Sattonnet C, Nahon P, Roudot-Thoraval F, Ziol M. Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort). Hepatology. 2018;68(4):1534-1548.
  45. Corre R, Gervais R, Guisier F, Tassy L, Vinas F, Lamy R, Fraboulet G, Greillier L, Doubre H, Descourt R, Chouaid C, Auliac J-B. Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study). Oncotarget. 2018;9(9):8253-8262.
  46. Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M, Schmutz JL, Beneton N, Mahé E, Viguier M, Chosidow O, Canoui-Poitrine F, Sbidian E. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. J Eur Acad Dermatol Venereol. 2018;32(11):1920-1929.
  47. Chouaid C, Assié JBaptiste, Andujar P, Blein C, Tournier C, Vainchtock A, Scherpereel A, Monnet I, Pairon JClaude. Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis. Cancer Med. 2018;7(4):1102-1109.
  48. Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazières J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenègre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B. Real-life experience of ceritinib in crizotinib-pretreated advanced non-small cell lung cancer patients. ERJ Open Res. 2018;4(1).
  49. de'Angelis N, Petrucciani N, Giannandrea G, Brunetti F. The protocol of low-impact laparoscopic cholecystectomy: the combination of mini-laparoscopy and low-pressure pneumoperitoneum. Updates Surg. 2018;70(4):553-556.
  50. Gellen B, Messonnier LA, Galactéros F, Audureau E, Merlet AN, Rupp T, Peyrot S, Martin C, Féasson L, Bartolucci P. Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial. Lancet Haematol. 2018;5(11):e554-e562.
  51. Petrucciani N, de'Angelis N, Brunetti F. Robotic Toupet fundoplication following Heller myotomy for achalasia (with video). J Visc Surg. 2018;155(5):427-428.
  52. Auliac JB, Bayle S, Vergnenegre A, Le Caer H, Falchero L, Gervais R, Doubre H, Vinas F, Marin B, Chouaid C. Patients with non-small-cell lung cancer harbouring a mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14. Curr Oncol. 2018;25(5):e398-e402.
  53. Le Corvoisier P, Gallet R, Lesault P-F, Audureau E, Paul M, Ternacle J, Ghostine S, Champagne S, Arrouasse R, Bitari D, Mouillet G, Dubois-Randé J-L, Berdeaux A, Ghaleh B, Deux J-F, Teiger E. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial. BMC Cardiovasc Disord. 2018;18(1):193.
  54. Scherpereel A, Durand-Zaleski I, Cotté F-E, Fernandes J, Debieuvre D, Blein C, Gaudin A-F, Tournier C, Vainchtock A, Chauvin P, Souquet P-J, Westeel V, Chouaid C. Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study. BMC Cancer. 2018;18(1):1013.
  55. Lesueur P, Escande A, Thariat J, Vauléon E, Monnet I, Cortot A, Lerouge D, Danhier S, Do P, Dubos-Arvis C, Chouaid C, Gervais R. Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC. Cancer Med. 2018;7(11):5505-5513.
  56. Bigay-Gamé L, Bota S, Greillier L, Monnet I, Madroszyk A, Corre R, Mastroianni B, Falchero L, Mazières J, Colineaux H, Lepage B, Chouaid C. Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France. Oncology. 2018;95(6):337-343.
  57. Derbez B, Z Haffaf E, Galactéros F, de Montgolfier S. [Prevention of genetic diseases : the return of the family practitioner ?]. Rev Epidemiol Sante Publique. 2018.
  58. Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz P-E, Revel M-P, Westeel V, Dixmier A, Trédaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria J-C, Friard S, Stern J-B, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani J-M, Alifano M, Chatellier G, Girard P. Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial. Eur Respir J. 2018;52(4).
  59. Franco I, de'Angelis N, Canoui-Poitrine F, Le Roy B, Courtot L, Voron T, Aprodu R, Salamé E, Saleh NBou, Berger A, Ouaïssi M, Altomare DFrancesco, Pezet D, Mutter D, Brunetti F, Memeo R. Feasibility and Safety of Laparoscopic Right Colectomy in Oldest-Old Patients with Colon Cancer: Results of the CLIMHET Study Group. J Laparoendosc Adv Surg Tech A. 2018;28(11):1326-1333.
  60. Lesueur P, Martel-Laffay I, Escande A, Kissel M, Locher C, Gervais R, Schott R, Vergnenègre A, Chouaid C. Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review. Expert Rev Anticancer Ther. 2018;18(11):1159-1165.
  61. Paillaud E, Soubeyran P, Caillet P, Cudennec T, Brain E, Terret C, Etchepare F, Mourey L, Aparicio T, Pamoukdjian F, Audisio RA, Rostoft S, Hurria A, Bellera C, Mathoulin-Pélissier S. Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey. Eur J Cancer. 2018;103:61-68.
  62. Chouaid C, Danson S, Andreas S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M-H, Barth J, Hoffmann H, Potter V, Barlesi F, Price M, Chirila C, Hollis K, Sweeney C, Wolowacz S, Kaye JA, Kontoudis I. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer. 2018;124:310-316.
  63. Andreas S, Chouaid C, Danson S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M-H, Barth J, Hoffmann H, Potter V, Barlesi F, Chirila C, Hollis K, Sweeney C, Price M, Wolowacz S, Kaye JA, Kontoudis I. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer. 2018;124:298-309.
  64. Bush SH, Lawlor PG, Ryan K, Centeno C, Lucchesi M, Kanji S, Siddiqi N, Morandi A, Davis DHJ, Laurent M, Schofield N, Barallat E, Ripamonti CI. Delirium in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv143-iv165.
  65. Costantini A, Corny J, Fallet V, Renet S, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Nguenang M, Jouveshomme S, Wislez M, Trédaniel J, Cadranel J. Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer. ERJ Open Res. 2018;4(2).
  66. Hersant B, SidAhmed-Mezi M, Belkacemi Y, Darmon F, Bastuji-Garin S, Werkoff G, Bosc R, Niddam J, Hermeziu O, La Padula S, Meningaud JPaul. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. 2018;25(10):1124-1130.
  67. Remy P, Audard V, Natella PAndré, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Sahlia NAit, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D. An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study). Kidney Int. 2018;94(6):1217-1226.
  68. Thuleau A, Dugay J, Dacremont C, Jemmali Z, Elard J, De Ricke Y, Cassoux N, Watson S, Escande M-C, Fromantin I. Volatile Organic Compounds of Malignant Breast Cancer Wounds: Identification and Odors. Wounds. 2018;30(11):337–344.
  69. Kofman T, Pourcine F, Canoui-Poitrine F, Kamar N, Malvezzi P, François H, Boutin E, Audard V, Lang P, Martinez F, Legendre C, Matignon M, Grimbert P. Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study. Transpl Int. 2018;31(4):377-385.
  70. Rwabihama J-P, Audureau E, Laurent M, Rakotoarisoa L, Jegou M, Saddedine S, Krypciak S, Herbaud S, Benzengli H, Segaux L, Guery E, Ambime G, Rabus M-T, Perilliat J-G, David J-P, Paillaud E. Prophylaxis of Venous Thromboembolism in Geriatric Settings: A Cluster-Randomized Multicomponent Interventional Trial. J Am Med Dir Assoc. 2018;19(6):497-503.
  71. Fonteyne V, Ost P, Bellmunt J, Droz JPierre, Mongiat-Artus P, Inman B, Paillaud E, Saad F, Ploussard G. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. Eur Urol. 2018;73(1):40-50.
  72. Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga J-M, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G. High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol. 2018;25(1):120-127.
  73. Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clin Nutr. 2018;37(4):1101-1113.

2017

  1. Debs T, Petrucciani N, Kassir R, Chassang M, Havet J, Piche T, Ben Amor I, Gugenheim J. Double Perforation of Marginal Ulcers after One Anastomosis Gastric Bypass with a Biliary Peritonitis. Obes Surg. 2017;27(11):2993-2995.
  2. Petrucciani N, Debs T, Nigri G, D'Angelo F, Gugenheim J, Ramacciato G. Borderline resectable pancreatic cancer: an evolving concept. Ann Oncol. 2017;28(9):2315.
  3. Debs T, Petrucciani N, Gugenheim J. Why Would a Patient Complain of Dysphagia and Heartburn After Multiple Bariatric Surgeries?. Gastroenterology. 2017;153(3):653-654.
  4. Aurello P, Petrucciani N', Sirimarco D, Mangogna LMaria, Nigri G, Valabrega S, D'Angelo F, Ramacciato G. Esophagectomy with Esophagocoloplasty for Malignancies: Indications, Technique (with Video), and Results. Systematic Review of the Literature. J Gastrointest Surg. 2017;21(9):1557-1561.
  5. Kassir R, Debs T, Petrucciani N, Tiffet O, Ben Amor I, Gugenheim J. Predictive Value of C-Reactive Protein for Complications Post-Laparoscopic Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(9):2460-2461.
  6. Kassir R, Lointier P, Tiffet O, Debs T, Petrucciani N, Kassir R, Ben Amor I, Gugenheim J. Revision bariatric surgery: What technical choices should be taken depending on the first intervention?. Int J Surg. 2017;44:7-8.
  7. Petrucciani N, Debs T, Kassir R, Ben Amor I, Gugenheim J. Gastric Bypass and Synchronous Cholecystectomy: a Matter of Numbers?. Obes Surg. 2017;27(8):2174-2176.
  8. Petrucciani N, Debs T, Ciampi D, Massalou D, Kassir R, Ben Amor I, Gugenheim J. Rare Cause of Small Bowel Ischemia During Pregnancy After Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(7):1879-1881.
  9. Aurello P, Petrucciani N, Antolino L, Giulitti D, D'Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: Is it time to tailor it?. World J Gastroenterol. 2017;23(19):3379-3387.
  10. Debs T, Petrucciani N, Kassir R, Vanbiervliet G, Ben Amor I, Staccini AMyx, Sejor E, Gugenheim J. Migration of an Endoscopic Double Pigtail Drain into the Abdominal Wall Placed as a Treatment of a Fistula Post Revisional Bariatric Surgery. Obes Surg. 2017;27(5):1335-1337.
  11. Ben Amor I, Petrucciani N, Kassir R, Munifi AAl, Piche T, Debs T, Gugenheim J. Laparoscopic Conversion of One Anastomosis Gastric Bypass to a Standard Roux-en-Y Gastric Bypass. Obes Surg. 2017;27(5):1398.
  12. Debs T, Petrucciani N, Kassir R, Ouvrier D, Frin AClaire, Ben Amor I, Gugenheim J. Chylous leak after pancreatic resection: A grading system was needed. Surgery. 2017;162(6):1345.
  13. Ramacciato G, Nigri G, Petrucciani N', Pinna ADaniele, Ravaioli M, Jovine E, Minni F, Grazi GLuca, Chirletti P, Tisone G, Ferla F, Napoli N', Boggi U. Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. BMC Surg. 2017;17(1):109.
  14. Le Caer H, Borget I, Corre R, Locher C, Raynaud C, Decroisette C, Bérard H, Audigier-Valette C, Dujon C, Auliac JBernard, Crequit J, Monnet I, Vergnenègre A, Chouaid C. Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group. J Thorac Dis. 2017;9(10):3747-3754.
  15. Paris C, Do P, Mastroianni B, Dixmier A, Dumont P, Pichon E, Chouaid C, Coudert B, Foucher P, Fraboulet S, Locatelli-Sanchez M, Baize N, Dansin E, Moreau L, Vincent M, Missy P, Morin F, Moro-Sibilot D, Couraud S. Association between lung cancer somatic mutations and occupational exposure in never-smokers. Eur Respir J. 2017;50(4).
  16. Tordrup D, Chouaid C, Cuijpers P, Dab W, van Dongen JMaria, Espin J, Jönsson B, Léonard C, McDaid D, McKee M, Miguel JPereira, Patel A, Reginster J-Y, Ricciardi W, van Molken MRutten-, Rupel VPrevolnik, Sach T, Sassi F, Waugh N, Bertollini R. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION. Int J Technol Assess Health Care. 2017;33(6):609-619.
  17. Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S. Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France. Clinicoecon Outcomes Res. 2017;9:655-668.
  18. Etienne H, Majewski M, Cochennec F, Segaux L, Becquemin J-P. Emergency Endovascular Interventions for Ruptured Descending Thoracic Aortic Aneurysm. Ann Vasc Surg. 2017;39:160-166.
  19. Azoulay D, Audureau E, Bhangui P, Belghiti J, Boillot O, Andreani P, Castaing D, Cherqui D, Irtan S, Calmus Y, Chazouillères O, Soubrane O, Luciani A, Féray C. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study. Ann Surg. 2017;266(6):1035-1044.
  20. Caillet P, Liuu E, Simon ARaynaud, Bonnefoy M, Guerin O, Berrut G, Lesourd B, Jeandel C, Ferry M, Rolland Y, Paillaud E. Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. Clin Nutr. 2017;36(6):1473-1482.
  21. Blondiaux E, Pidial L, Autret G, Rahmi G, Balvay D, Audureau E, Wilhelm C, Guerin CL, Bruneval P, Silvestre J-S, Menasché P, Clément O. Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction. J Tissue Eng Regen Med. 2017;11(12):3417-3427.
  22. Ernande L, Audureau E, Jellis CL, Bergerot C, Henegar C, Sawaki D, Czibik G, Volpi C, Canoui-Poitrine F, Thibault H, Ternacle J, Moulin P, Marwick TH, Derumeaux G. Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus. J Am Coll Cardiol. 2017;70(14):1704-1716.
  23. Baize N, Monnet I, Greillier L, Quere G, Kerjouan M, Janicot H, Vergnenègre A, Auliac JBernard, Chouaid C. Second-line treatments of small-cell lung cancers. Expert Rev Anticancer Ther. 2017;17(11):1033-1043.
  24. Deux J-F, Audard V, Brugières P, Habibi A, Manea E-M, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises. Am J Kidney Dis. 2017;69(1):51-59.
  25. Auliac J-B, Monnet I, Dubos-Arvis C, Chiappa AMarie, Baize N, Bota S, Vergnenègre A, Doubre H, Locher C, Bizieux A, Robinet G, Chouaid C. Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study). Target Oncol. 2017;12(6):833-838.
  26. Audureau E, Hua C, de Prost N, Hemery F, Decousser JW, Bosc R, Lepeule R, Chosidow O, Sbidian E. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12. Br J Dermatol. 2017;177(6):1575-1582.
  27. Delva F, Margery J, Laurent F, Petitprez K, Pairon J-C. Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations. BMC Public Health. 2017;17(1):191.
  28. Chouaid C, Luciani L, LeLay K, Do P, Bennouna J, Perol M, Moro-Sibilot D, Vergnenègre A, de Pouvourville G. Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers. J Thorac Oncol. 2017;12(10):1496-1502.
  29. Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E. Cost analysis of adverse events associated with non-small cell lung cancer management in France. Clinicoecon Outcomes Res. 2017;9:443-449.
  30. Chouaid C, Falchero L, Schott R, Bonnetain F, Taguieva-Pioger N, Bennouna J. [Bevacizumab in combination with first-line treatment for metastatic non-small cell lung cancer in clinical practice. Results of the EOLE study]. Rev Mal Respir. 2017;34(1):36-43.
  31. Chouaid C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, Blein C, Gaudin A-F, Ozan N, Leblanc S, Vainchtock A, Chauvin P, Cotté F-E, Souquet P-J. Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). PLoS One. 2017;12(8):e0182798.
  32. Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S. Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial. Intensive Care Med. 2017;43(11):1613-1625.
  33. Caliez J, Monnet I, Pujals A, Rousseau-Bussac G, Jabot L, Boudjemaa A, Leroy K, Chouaid C. [Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement]. Rev Mal Respir. 2017;34(5):576-580.
  34. Cadier B, Bulsei J, Nahon P, Seror O, Laurent A, Rosa I, Layese R, Costentin C, Cagnot C, Durand-Zaleski I, Chevreul K. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States. Hepatology. 2017;65(4):1237-1248.
  35. Jourjon R, Morel B, Irtan S, Audureau E, Coulomb-L'Herminé A, Larroquet M, le Pointe HDucou, Blondiaux E. Analysis of Clinical and Ultrasound Determinants of Adnexal Torsion in Children and Adolescents. J Pediatr Adolesc Gynecol. 2017;30(5):582-590.
  36. Bylicki O, Paleiron N, Margery J, Guisier F, Vergnenègre A, Robinet G, Auliac J-B, Gervais R, Chouaid C. Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer. Target Oncol. 2017;12(5):563-569.
  37. Gross J, Oubaya N, Eymard F, Hourdille A, Chevalier X, Guignard S. Stressful life events as a trigger for rheumatoid arthritis onset within a year: a case-control study. Scand J Rheumatol. 2017;46(6):507-508.
  38. Boussageon R, Pouchain D, Renard V. Prevention of complications in type 2 diabetes: is drug glucose control evidence based?. Br J Gen Pract. 2017;67(655):85-87.
  39. Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet J-M, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier A-L, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X. Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis. J Crohns Colitis. 2017;11(8):930-935.
  40. Paillaud E, Canoui-Poitrine F, Varnier G, Anfasi-Ebadi N, Guery E, Saint-Jean O, Gisselbrecht M, Aparicio T, Bastuji-Garin S, Laurent M, Caillet P. Preferences about information and decision-making among older patients with and without cancer. Age Ageing. 2017;46(4):665-671.
  41. Toumi M, Motrunich A, Millier A, Rémuzat C, Chouaid C, Falissard B, Aballéa S. Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment. J Mark Access Health Policy. 2017;5(1):1344088.
  42. Oubaya N, Dramé M, Novella J-L, Quignard E, Cunin C, Jolly D, Mahmoudi R. Screening for frailty in community-dwelling elderly subjects: Predictive validity of the modified SEGA instrument. Arch Gerontol Geriatr. 2017;73:177-181.
  43. Touma J, Kashi M, Oubaya N, Cochennec F, Allaire E, Marzelle J, Becquemin J-P, Desgranges P. Results of Cryopreserved Arterial Allografts to Treat Infections of Peripheral Bypasses. Ann Vasc Surg. 2017;38:e2.
  44. Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, Miglioresi L, Vitale A, Vennarecci G, Ambrosio CD, Burra P, Di Benedetto F, Fagiuoli S, Colasanti M, Ettorre GMaria, Andreoli A, Cillo U, Laurent A, Katsahian S, Audureau E, Roudot-Thoraval F, Duvoux C. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. J Hepatol. 2017;66(3):552-559.
  45. Ternacle J, Wan F, Sawaki D, Surenaud M, Pini M, Mercedes R, Ernande L, Audureau E, Dubois-Randé J-L, Adnot S, Hue S, Czibik G, Derumeaux G. Short-term high-fat diet compromises myocardial function: a radial strain rate imaging study. Eur Heart J Cardiovasc Imaging. 2017;18(11):1283-1291.
  46. Natella P-A, Le Corvoisier P, Paillaud E, Renaud B, Mahé I, Bergmann J-F, Perchet H, Mottier D, Montagne O, Bastuji-Garin S. Long-term mortality in older patients discharged after acute decompensated heart failure: a prospective cohort study. BMC Geriatr. 2017;17(1):34.
  47. Nahon P, Lescat M, Layese R, Bourcier V, Talmat N, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Goria O, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Trinchet J-C, Moreau R, Roudot-Thoraval F. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut. 2017;66(2):330-341.
  48. Stücker I, Martin D, Neri M, Laurent-Puig P, Blons H, Antoine M, Guiochon-Mantel A, Brailly-Tabard S, Canonico M, Wislez M, Trédaniel J. Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank. BMC Public Health. 2017;17(1):324.
  49. Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Leroy V, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Dharancy S, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. Gastroenterology. 2017;152(1):142-156.e2.
  50. Moktefi A, Parisot J, Desvaux D, Canoui-Poitrine F, Brocheriou I, Peltier J, Audard V, Kofman T, Suberbielle C, Lang P, Rondeau E, Grimbert P, Matignon M. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study. Transpl Int. 2017;30(3):277-287.
  51. Rahmi G, Vinet M-A, Perrod G, Saurin J-C, Samaha E, Ponchon T, Canard J-M, Edery J, Maoulida H, Chatellier G, Durand-Zaleski I, Cellier C. Efficacy of double-balloon enteroscopy for small-bowel polypectomy: clinical and economic evaluation. Therap Adv Gastroenterol. 2017;10(6):465-472.
  52. Matignon M, Pilon C, Commereuc M, Grondin C, Leibler C, Kofman T, Audard V, Cohen J, Canoui-Poitrine F, Grimbert P. Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study. PLoS One. 2017;12(6):e0178572.
  53. Pouessel D, Bastuji-Garin S, Houédé N, Vordos D, Loriot Y, Chevreau C, Sevin E, Beuzeboc P, de la Taille A, Le Thuaut A, Allory Y, Culine S. Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort. Clin Genitourin Cancer. 2017;15(1):e45-e52.
  54. Plichart M, Orvoën G, Jourdain P, Quinquis L, Coste J, Escande M, Friocourt P, Paillaud E, Chedhomme F-X, Labourée F, Boully C, Benetos A, Domerego J-J, Komajda M, Hanon O. Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study. Eur J Heart Fail. 2017;19(4):540-548.
  55. Laurent M, Brureau L, Demery MEl, Fléchon A, Le Thuaut A, Carvahlo-Verlinde M, Bastuji-Garin S, Paillaud E, Canoui-Poitrine F, Culine S. Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study. Urol Oncol. 2017;35(1):34.e9-34.e16.
  56. Paul E, Franco-Montoya M-L, Paineau E, Angeletti B, Vibhushan S, Ridoux A, Tiendrebeogo A, Salome M, Hesse B, Vantelon D, Rose J, Canoui-Poitrine F, Boczkowski J, Lanone S, Delacourt C, Pairon J-C. Pulmonary exposure to metallic nanomaterials during pregnancy irreversibly impairs lung development of the offspring. Nanotoxicology. 2017;11(4):484-495.
  57. Ladner J, Rodrigues M, Davis B, Besson M-H, Audureau E, Saba J. Societal impact of dengue outbreaks: Stakeholder perceptions and related implications. A qualitative study in Brazil, 2015. PLoS Negl Trop Dis. 2017;11(3):e0005366.
  58. Parpaleix A, Boyer L, Wiedemann A, Lacabaratz C, Margarit L, Enouf V, Le Corvoisier P, Lino A, Covali-Noroc A, Housset B, Chouaid C, Maitre B, Levy Y, Lelièvre J-D, Adnot S. Impaired humoral and cellular immune responses to influenza vaccination in chronic obstructive pulmonary disease patients. J Allergy Clin Immunol. 2017;140(6):1754-1757.e6.
  59. Pamoukdjian F, Lévy V, Sebbane G, Boubaya M, Landre T, Bloch-Queyrat C, Paillaud E, Zelek L. Slow Gait Speed Is an Independent Predictor of Early Death in Older Cancer Outpatients: Results from a Prospective Cohort Study. J Nutr Health Aging. 2017;21(2):202-206.
  60. Winter A, Féray C, Audureau E, Écochard R, Jacquelinet C, Roudot-Thoraval F, Duvoux C, Daurès J-P, Landais P. External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry. Liver Int. 2017;37(8):1229-1238.

2016

  1. Petrucciani N', Nigri G, Debs T, Giannini G, Sborlini E, Antolino L, Aurello P, D'Angelo F, Gugenheim J, Ramacciato G. Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: Does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatology. 2016;16(6):1037-1043.
  2. Cabaret O, Bonnal C, Canoui-Poitrine F, Emirian A, Bizouard G, Levesque E, Maitre B, Fihman V, Decousser J-W, Botterel F. Concomitant presence of Aspergillus fumigatus and Stenotrophomonas maltophilia in the respiratory tract: a new risk for patients with liver disease?. J Med Microbiol. 2016;65(5):414-9.
  3. Boyer L, Audureau E, Margarit L, Marcos E, Bizard E, Le Corvoisier P, Macquin-Mavier I, Derumeaux G, Damy T, Drouot X, Covali-Noroc A, Boczkowski J, Bastuji-Garin S, Adnot S. Telomere Shortening in Middle-Aged Men with Sleep-disordered Breathing. Ann Am Thorac Soc. 2016;13(7):1136-43.
  4. Blondiaux E, Laurent M, Audureau E, Boudjemaa S, Sileo C, Lenoir M, Dainese L, Garel C, Coulomb A, le Pointe HDucou. Factors influencing the diagnostic yield and accuracy of image-guided percutaneous needle biopsy of pediatric tumors: single-center audit of a 26-year experience. Pediatr Radiol. 2016;46(3):372-82.
  5. Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MGeorgine, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galactéros F, Audard V. Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease. J Am Soc Nephrol. 2016;27(6):1847-53.
  6. Balkau B, Halimi S, Blickle J-F, Vergès B, Avignon A, Attali C, Chartier I, Amelineau E. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study. Ann Endocrinol (Paris). 2016;77(6):649-657.
  7. Auliac JB, Fournier C, C Valette A, Perol M, Bizieux A, Vinas F, C van Ho DPhan, S Ouchlif B, Corre R, Le Garff G, Fournel P, Baize N, Lamy R, Vergnenegre A, Arpin D, Marin B, Chouaid C, Gervais R. Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study. Target Oncol. 2016;11(2):167-74.
  8. Aparicio T, Pamoukdjian F, Quero L, Manfredi S, Wind P, Paillaud E. Colorectal cancer care in elderly patients: Unsolved issues. Dig Liver Dis. 2016;48(10):1112-8.
  9. Aparicio T, Francois E, Cristol-Dalstein L, Carola E, Maillard E, Paillaud E, Retornaz F, Faroux R, André T, Bedenne L, Seitz J-F. PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial. Dig Liver Dis. 2016;48(2):206-7.
  10. Dweik BAl, Redjoul R, Bastuji-Garin S, Beckerich F, Robin C, Pautas C, Toma A, Cabanne L, Maury S, Cordonnier C. Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration. Am J Hematol. 2016;91(4):E276-8.
  11. Haddad B, Winer N, Chitrit Y, Houfflin-Debarge V, Chauleur C, Bages K, Tsatsaris V, Benachi A, Bretelle F, Gris J-C, Bastuji-Garin S. Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial. Obstet Gynecol. 2016;128(5):1053-1063.
  12. Carsin-Vu A, Oubaya N, Mulé S, Janvier A, Delemer B, Soyer P, Hoeffel C. MDCT Linear and Volumetric Analysis of Adrenal Glands: Normative Data and Multiparametric Assessment. Eur Radiol. 2016;26(8):2494-501.
  13. Gellen B, Canoui-Poitrine F, Boyer L, Drouot X, Le Thuaut A, Bodez D, Covali-Noroc A, D'ortho MPia, Guendouz S, Rappeneau S, Kharoubi M, Dubois-Randé J-L, Hittinger L, Adnot S, Bastuji-Garin S, Damy T. Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target?. Int J Cardiol. 2016;203:1022-8.
  14. Ganne-Carrié N, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J-P, Zarski J-P, Riachi G, Calès P, Péron J-M, Alric L, Bourlière M, Mathurin P, Blanc J-F, Abergel A, Serfaty L, Mallat A, Grangé J-D, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Trinchet J-C, Nahon P, Roudot-Thoraval F. Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir). Hepatology. 2016;64(4):1136-47.
  15. Galat A, Guellich A, Bodez D, Slama M, Dijos M, Zeitoun DMessika, Milleron O, Attias D, Dubois-Randé J-L, Mohty D, Audureau E, Teiger E, Rosso J, Monin J-L, Damy T. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?. Eur Heart J. 2016;37(47):3525-3531.
  16. Lim C, Audureau E, Salloum C, Levesque E, Lahat E, Merle JClaude, Compagnon P, Dhonneur G, Féray C, Azoulay D. Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value. HPB (Oxford). 2016;18(6):540-8.
  17. Fournel P, Vergnenègre A, Robinet G, Lena H, Gervais R, Le Caer H, Souquet P-J, Chavaillon J-M, Bozonnat M-C, Daurès J-P, Chouaid C, Martel-Lafay I. Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01. Eur J Cancer. 2016;52:181-7.
  18. Le Breton J, Ferrat E, Attali C, Bercier S, Le Corvoisier P, Brixi Z, Veerabudun K, Renard V, Bastuji-Garin S. Effect of reminders mailed to general practitioners on colorectal cancer screening adherence: a cluster-randomized trial. Eur J Cancer Prev. 2016;25(5):380-7.
  19. Ferrat E, Le Breton J, Guéry E, Adeline F, Audureau E, Montagne O, Roudot-Thoraval F, Attali C, Le Corvoisier P, Renard V. Effects 4.5 years after an interactive GP educational seminar on antibiotic therapy for respiratory tract infections: a randomized controlled trial. Fam Pract. 2016;33(2):192-9.
  20. Lazzati A, Audureau E, Hemery F, Schneck A-S, Gugenheim J, Azoulay D, Iannelli A. Reduction in early mortality outcomes after bariatric surgery in France between 2007 and 2012: A nationwide study of 133,000 obese patients. Surgery. 2016;159(2):467-74.
  21. Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, Van Ganse E. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respir Med. 2016;117:33-9.
  22. Di Liberto G, Kiger L, Marden MC, Boyer L, Poitrine FCanoui, Conti M, Rakotoson MGeorgine, Habibi A, Khorgami S, Vingert B, Maitre B, Galactéros F, Pirenne F, Bartolucci P. Dense red blood cell and oxygen desaturation in sickle-cell disease. Am J Hematol. 2016;91(10):1008-13.
  23. David J-P, Ferrat E, Parisot J, Naga H, Lakroun S, Menasria F, Saddedine S, Natella P-A, Paillaud E, Fromantin I, Bastuji-Garin S. White Matter Lesions: Prevalence and Clinical Phenotype in Asymptomatic Individuals Aged ≥50 Years. Dement Geriatr Cogn Disord. 2016;42(3-4):159-168.
  24. Krypciak S, Liuu E, Minard A, Obraztsova A, Paillaud E. [Orthostatic hypotension in elderly: a case-control study]. Soins Gerontol. 2016;(117):37-43.
  25. Damy T, Costes B, Hagège AA, Donal E, Eicher J-C, Slama M, Guellich A, Rappeneau S, Gueffet J-P, Logeart D, Planté-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Randé J-L, Goossens M, Canoui-Poitrine F, Buxbaum JN. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J. 2016;37(23):1826-34.
  26. Kempf E, Caillet P, Rousseau B, Le Thuaut A, Bastuji-Garin S, Liuu E, Lagrange J-L, Tournigand C, Paillaud E, Canoui-Poitrine F. What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA-08 Cohort Study. J Am Geriatr Soc. 2016;64(6):1360-2.
  27. Créquit P, Ruppert A-M, Rozensztajn N, Gounant V, Vieira T, Poulot V, Antoine M, Chouaid C, Wislez M, Cadranel J, Lavole A. EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients. Lung Cancer. 2016;96:74-7.
  28. Kanagaratnam L, Dramé M, Trenque T, Oubaya N, Nazeyrollas P, Novella J-L, Jolly D, Mahmoudi R. Adverse drug reactions in elderly patients with cognitive disorders: A systematic review. Maturitas. 2016;85:56-63.
  29. Corre R, Lena H, Vergnenègre A, Chouaid C. Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al. J Clin Oncol. 2016;34(33):4050-4051.
  30. Hureaux J, Couturier O, Lacœuille F, Bouchet F, Chouaid C, Saulnier P, Urban T. [Can positron emission tomography assessment of response to treatment help to individualize use of erlotinib in non-small cell lung cancer?]. Rev Mal Respir. 2016;33(9):817-823.
  31. Corre R, Greillier L, Le Caer H, Audigier-Valette C, Baize N, Bérard H, Falchero L, Monnet I, Dansin E, Vergnenègre A, Marcq M, Decroisette C, Auliac J-B, Bota S, Lamy R, Massuti B, Dujon C, Perol M, Daurès J-P, Descourt R, Lena H, Plassot C, Chouaid C. Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. J Clin Oncol. 2016;34(13):1476-83.
  32. Hélage S, Revel MP, Chabi ML, Audureau E, Ferretti G, Laurent F, Alifano M, Mansuet-Lupo A, Buy JN, Vadrot D. Solitary fibrous tumor of the pleura: Can computed tomography features help predict malignancy? A series of 56 patients with histopathological correlates. Diagn Interv Imaging. 2016;97(3):347-53.
  33. Chouaid C, Borget I, Braun E, Bazil M-L, Schaetz D, Rémuzat C, Toumi M. French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends. Target Oncol. 2016;11(4):515-34.
  34. Hanaire H, Attali C, Lecointre B, Fraysse M, Gouet D, Babel M-R, Charbonnel B, Sarkozy F, Gourmelen J, Detournay B. [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization]. Sante Publique. 2016;28(6):781-789.
  35. Chaput U, Vienne A, Audureau E, Bauret P, Bichard P, Coumaros D, Napoléon B, Ponchon T, Duchmann J-C, Laugier R, Lamouliatte H, Védrenne B, Gaudric M, Chaussade S, Robin F, Leblanc S, Prat F. Temporary placement of fully covered self-expandable metal stents for the treatment of benign biliary strictures. United European Gastroenterol J. 2016;4(3):403-12.
  36. Nielsen L, Canoui-Poitrine F, Jais J-P, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V. Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients. Br J Haematol. 2016;174(1):148-52.
  37. Muller N, Amiot A, Le Thuaut A, Bastuji-Garin S, Deforges L, Delchier J-C. Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains. Clin Res Hepatol Gastroenterol. 2016;40(4):517-24.
  38. Louvel G, Metellus P, Noel G, Peeters S, Guyotat J, Duntze J, Le Reste P-J, Hieu PDam, Faillot T, Litre F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes J-R, Barat J-L, Langlois O, Menei P, Dumont SN, Zanello M, Dezamis E, Dhermain F, Pallud J. Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients. Radiother Oncol. 2016;118(1):9-15.
  39. Liuu E, Caillet P, Curé H, Anfasi N, De Decker L, Pamoukdjian F, Canoui-Poitrine F, Soubeyran P, Paillaud E. [Comprehensive geriatric assessment (CGA) in elderly with cancer: For whom?]. Rev Med Interne. 2016;37(7):480-8.
  40. Yiou R, Bütow Z, Parisot J, Lingombet O, Augustin D, de la Taille A, Salomon L, Audureau E. Update on 2-year outcomes of the TOMS™ transobturator male sling for the treatment of male stress urinary incontinence. Neurourol Urodyn. 2016;35(1):44-7.
  41. Vinas F, Ben Hassen I, Jabot L, Monnet I, Chouaid C. Delays for diagnosis and treatment of lung cancers: a systematic review. Clin Respir J. 2016;10(3):267-71.
  42. Vergnenègre A, Massuti B, de Marinis F, Carcereny E, Felip E, Do P, Sanchez JMiguel, Paz-Arez L, Chouaid C, Rosell R. Economic Analysis of First-Line Treatment with Erlotinib in an EGFR-Mutated Population with Advanced NSCLC. J Thorac Oncol. 2016;11(6):801-7.
  43. Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, Radu C, Guendouz S, Couetil J-P, Benhaiem N, Hittinger L, Dubois-Randé J-L, Planté-Bordeneuve V, Mohty D, Deux J-F, Damy T. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016;9(2):126-38.
  44. Tardieu É, Mahmoudi R, Novella J-L, Oubaya N, Blanchard F, Jolly D, Dramé M. [External validation of the short emergency geriatric assessment (SEGA) instrument on the SAFES cohort]. Geriatr Psychol Neuropsychiatr Vieil. 2016;14(1):49-55.
  45. Soyez F, Ninot G, Herkert A, S Huyn P, Prosper M, Chinet T, Housset B, Chouaid C, Roche N. [Validation of an evaluation questionnaire for COPD acute exacerbations (Exascore)]. Rev Mal Respir. 2016;33(1):17-24.
  46. Schuler M, Yang JC-H, Park K, Kim J-H, Bennouna J, Chen Y-M, Chouaid C, De Marinis F, Feng J-F, Grossi F, Kim D-W, Liu X, Lu S, Strausz J, Vinnyk Y, Wiewrodt R, Zhou C, Wang B, Chand VK, Planchard D. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial. Ann Oncol. 2016;27(3):417-23.
  47. Quoix E, Lena H, Losonczy G, Forget F, Chouaid C, Papai Z, Gervais R, Ottensmeier C, Szczesna A, Kazarnowicz A, Beck JT, Westeel V, Felip E, Debieuvre D, Madroszyk A, Adam J, Lacoste G, Tavernaro A, Bastien B, Halluard C, Palanché T, Limacher J-M. TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial. Lancet Oncol. 2016;17(2):212-223.
  48. Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaid C. Targeted therapy for localized non-small-cell lung cancer: a review. Onco Targets Ther. 2016;9:4099-104.

2015

  1. Cittée J, Sauteron B, Brossier S, Ferrat E, Attali C, Chouaid C, Housset B. [In Process Citation]. Sante Publique. 2015;1 Suppl:177-87.
  2. Bazire L, Fromantin I, Diallo A, de la Lande B, Pernin V, Dendale R, Fourquet A, Savignoni A, Kirova YM. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. Radiother Oncol. 2015;117(2):229-33.
  3. Chouaid C, Borget I, Braun E, Bazil M, Schaetz D, Rémuzat C, Toumi M. French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends. Value Health. 2015;18(7):A489.
  4. Boyer L, Chouaid C, Bastuji-Garin S, Marcos E, Margarit L, Le Corvoisier P, Vervoitte L, Hamidou L, Frih L, Audureau E, Covali-Noroc A, Andujar P, Saakashvili Z, Lino A, Ghaleh B, Hue S, Derumeaux G, Housset B, Dubois-Randé J-L, Boczkowski J, Maitre B, Adnot S. Aging-related systemic manifestations in COPD patients and cigarette smokers. PLoS One. 2015;10(3):e0121539.
  5. Boulanger-Scemama E, Querques G, About F, Puche N, Srour M, Mane V, Massamba N, Canoui-Poitrine F, Souied EH. Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting. J Fr Ophtalmol. 2015;38(7):620-7.
  6. Bonnefoy M, Berrut G, Lesourd B, Ferry M, Gilbert T, Guérin O, Hanon O, Jeandel C, Paillaud E, Raynaud-Simon A, Ruault G, Rolland Y. Frailty and nutrition: searching for evidence. J Nutr Health Aging. 2015;19(3):250-7.
  7. Gandré C, Prigent A, Kemel M-L, Leboyer M, Chevreul K. Evolution of public and non-profit funding for mental health research in France between 2007 and 2011. Eur Neuropsychopharmacol. 2015;25(12):2339-48.
  8. Besse B, Le Moulec S, Mazières J, Senellart H, Barlesi F, Chouaid C, Dansin E, Bérard H, Falchero L, Gervais R, Robinet G, Ruppert A-M, Schott R, Lena H, Clément-Duchêne C, Quantin X, Souquet PJean, Trédaniel J, Moro-Sibilot D, Perol M, Madroszyk A-C, Soria J-C. Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study. Clin Cancer Res. 2015;21(8):1896-903.
  9. Gallet R, Meyer G, Ternacle J, Biendel C, Brunet A, Meneveau N, Rosario R, Couturaud F, Sebbane M, Lamblin N, Bouvaist H, Coste P, Maitre B, Bastuji-Garin S, Dubois-Randé J-L, Lim P. Diuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study. BMJ Open. 2015;5(5):e007466.
  10. Barlesi F, Chouaid C, Crequit J, Le Caer H, Pujol J-L, Legodec J, Vergnenègre A, Le Treut J, Fabre-Guillevin E, Loundou A, Auquier P, Simeoni M-C, Thomas PA. A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective. Interact Cardiovasc Thorac Surg. 2015;20(6):783-90.
  11. Ferrat E, Paillaud E, Laurent M, Le Thuaut A, Caillet P, Tournigand C, Lagrange J-L, Canoui-Poitrine F, Bastuji-Garin S. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. J Gerontol A Biol Sci Med Sci. 2015;70(9):1148-55.
  12. Esteban H, Blondiaux E, Audureau E, Sileo C, Moutard ML, Gelot A, Jouannic JM, H le Pointe D, Garel C. Prenatal features of isolated subependymal pseudocysts associated with adverse pregnancy outcome. Ultrasound Obstet Gynecol. 2015;46(6):678-87.
  13. Durand-Zaleski I, Rabetrano H, Devonec M, Mandron E, Soulie M, De la Taille A, Benoit G, Mottet N, Gasman D, Dore B, Zerbib M, Vaessen C, Irani J, Lebret T, Colombel M, Lechevallier E, Bastuji-Garin S, Allory Y, Abbou C, Rischmann P, Salomon L. [Not Available]. Prog Urol. 2015;25(13):742.
  14. Couraud S, Souquet P-J, Paris C, Do P, Doubre H, Pichon E, Dixmier A, Monnet I, Etienne-Mastroianni B, Vincent M, Trédaniel J, Perrichon M, Foucher P, Coudert B, Moro-Sibilot D, Dansin E, Labonne S, Missy P, Morin F, Blanché H, Zalcman G. BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers. Eur Respir J. 2015;45(5):1403-14.
  15. Couraud S, Debieuvre D, Moreau L, Dumont P, Margery J, Quoix E, Duvert B, Cellerin L, Baize N, Taviot B, Coudurier M, Cadranel J, Missy P, Morin F, Mornex J-F, Zalcman G, Souquet P-J. No impact of passive smoke on the somatic profile of lung cancers in never-smokers. Eur Respir J. 2015;45(5):1415-25.
  16. Coolen N, Morand P, Martin C, Hubert D, Kanaan R, Chapron J, Honoré I, Dusser D, Audureau E, Veziris N, Burgel P-R. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. J Cyst Fibros. 2015;14(5):594-9.
  17. Cittée J, Sauteron B, Brossier S, Ferrat E, Attali C, Chouaid C, Housset B. [COPD patient care pathways: points of view of hospital personnel]. Sante Publique. 2015;27(1 Suppl):S177-87.
  18. Chouaid C, Rémuzat C, Caban A, Toumi M. Is Oncology Drug Financial Toxicity A Specific Us Issue?. Value Health. 2015;18(7):A573.
  19. Rakotoson MGeorgine, Di Liberto G, Audureau E, Habibi A, Fauroux C, Khorgami S, Hulin A, Loric S, Noizat-Pirenne F, Galactéros F, Bartolucci P. Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea. Orphanet J Rare Dis. 2015;10:57.
  20. Krypciak S, Liuu E, Vincenot M, Landelle C, Lesprit P, Cariot M-A, Mézière A, Taillandier-Hériche E, Leroux J-L, Canoui-Poitrine F, Paillaud E. [Improvement of pneumococcal immunization coverage in older patients]. Rev Med Interne. 2015;36(4):243-7.
  21. Paz-Ares L, Mezger J, Ciuleanu TE, Fischer JR, von Pawel J, Provencio M, Kazarnowicz A, Losonczy G, de Castro G, Szczesna A, Crino L, Reck M, Ramlau R, Ulsperger E, Schumann C, Miziara JElias A, Lessa ÁE, Dediu M, Bálint B, Depenbrock H, Soldatenkova V, Kurek R, Hirsch FR, Thatcher N, Socinski MA. Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study. Lancet Oncol. 2015;16(3):328-37.
  22. Hurabielle C, Ingen-Housz-Oro S, Ortonne N, Cornillet-Lefèbvre P, Merah A, D'Incan M, Joly P, Franck N, Estève E, Maubec E, Grange F, Machet L, Laroche L, Barete S, Dalac S, Mortier L, Michel C, Quereux G, Saiag P, Ram-Wolff C, Lenormand B, Wechsler J, Bastuji-Garin S, Bagot M, Delfau-Larue MH. Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group. Br J Dermatol. 2015;173(4):1015-23.
  23. Parisot J, Penso-Assathiany D, Farcet Y, Raynaud E, Consigny S, Feton-Danou N, Bastuji-Garin S. [Outpatient expectations in dermatology consultations: A pilot study]. Ann Dermatol Venereol. 2015;142(11):639-45.
  24. Hocine A, Belmokhtar K, Bauley K, Jaisson S, Gaha K, Oubaya N, Lesaffre F, Lavaud S, Halin P, Gillery P, Rieu P, Touré F. Serum and Tissue Accumulation of Advanced Glycation End-Products Correlates with Vascular Changes. Perit Dial Int. 2015;35(5):592-4.
  25. Parisot J, Damy T, Gellen B, Covali-Noroc A, Bodez D, Rappeneau S, Guellich A, Adnot S, Bastuji-Garin S, Hittinger L, d'Ortho M-P, Boyer L, Canoui-Poitrine F. Sleep-disordered breathing in chronic heart failure: development and validation of a clinical screening score. Sleep Med. 2015;16(9):1094-101.
  26. Pamoukdjian F, Paillaud E, Zelek L, Laurent M, Lévy V, Landre T, Sebbane G. Measurement of gait speed in older adults to identify complications associated with frailty: A systematic review. J Geriatr Oncol. 2015;6(6):484-96.
  27. Pallud J, Audureau E, Noel G, Corns R, Lechapt-Zalcman E, Duntze J, Pavlov V, Guyotat J, Hieu PDam, Le Reste P-J, Faillot T, Litre C-F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes J-R, Barat J-L, Langlois O, Dezamis E, Parraga E, Zanello M, Nader E, Lefranc M, Bauchet L, Devaux B, Menei P, Metellus P. Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort. Neuro Oncol. 2015;17(12):1609-19.
  28. Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S, Wechsler J, de Feraudy S, Duong T-A, Delfau-Larue M-H, Chosidow O, Wolkenstein P, Roujeau J-C. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. Br J Dermatol. 2015;173(1):50-8.
  29. Moro-Sibilot D, Audigier-Valette C, Merle P, Quoix E, Souquet P-J, Barlesi F, Chouaid C, Molinier O, Bennouna J, Lavole A, Mazières J, Toffart A-C, Langlais A, Morin F, Zalcman G. Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study). Lung Cancer. 2015;89(2):139-45.
  30. Matignon M, Aissat A, Canoui-Poitrine F, Grondin C, Pilon C, Desvaux D, Saadoun D, Barathon Q, Garrido M, Audard V, Remy P, Lang P, Cohen J, Grimbert P. Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection. Am J Transplant. 2015;15(10):2718-25.
  31. Letrilliart L, Pouchain D, Le Reste J-Y, Renard V. [Letter on the editorial: "Early diagnosis of Alzheimer's disease: Are we too close to the tree to see the forest?"]. Presse Med. 2015;44(5):577-8.
  32. Laurendeau C, Chouaid C, Roche N, Terrioux P, Gourmelen J, Detournay B. [Management and costs of chronic pulmonary obstructive disease in France in 2011]. Rev Mal Respir. 2015;32(7):682-91.
  33. Launay N, Silvera S, Tenenbaum F, Groussin L, Tissier F, Audureau E, Vignaux O, Dousset B, Bertagna X, Legmann P. Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses. Int J Endocrinol. 2015;2015:213875.
  34. Yiou R, Loche C-M, Lingombet O, Abbou C, Salomon L, de la Taille A, Audureau E. Evaluation of urinary symptoms in patients with post-prostatectomy urinary incontinence treated with the male sling TOMS. Neurourol Urodyn. 2015;34(1):12-7.
  35. Raynaud C, Greillier L, Mazieres J, Monnet I, Mastroianni B, Robinet G, Fraboulet G, Dixmier A, Berard H, Lamy R, Letreut J, Lena H, Oliviero G, Botta S, Vergnenegre A, Borget I, Chouaid C. Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study). BMC Cancer. 2015;15:857.
  36. Yiou R, Bütow Z, Parisot J, Binhas M, Lingombet O, Augustin D, de la Taille A, Audureau E. Is it worth continuing sexual rehabilitation after radical prostatectomy with intracavernous injection of alprostadil for more than 1 year?. Sex Med. 2015;3(1):42-8.
  37. Yiou R, Audureau E, Loche C-M, Dussaud M, Lingombet O, Binhas M. Comprehensive evaluation of embarrassment and pain associated with invasive urodynamics. Neurourol Urodyn. 2015;34(2):156-60.
  38. Walzer S, Chouaid C, Lister J, Gultyaev D, Vergnenègre A, de Marinis F, Meng J, Carpeno Jde Castro, Crott R, Kleman M, Ngoh C. Simulation and comparison of progression-free survival among patients with non-squamous non-small-cell lung cancer receiving sequential therapy. Expert Rev Anticancer Ther. 2015;15(1):121-8.
  39. Toumi M, Rémuzat C, E Hammi E, Millier A, Aballéa S, Chouaid C, Falissard B. Current Process and Future Path for Health Economic Assessment of Pharmaceuticals in France. Value Health. 2015;18(7):A521.
  40. Toffart A-C, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit J-F. Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units. Intensive Care Med. 2015;41(1):164-5.
  41. Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2015;16(7):763-74.
  42. Sesé L, Didier M, Rousseau-Bussac G, Crequit P, Masanes MJ, Chouaid C. [Chemotherapy at the end of life for patients with lung cancer. A practice analysis]. Rev Mal Respir. 2015;32(3):256-61.
  43. Schmid-Bindert G, Engel-Riedel W, Reck M, Schuette W, Stöhlmacher J, Fischer JR, Mazières J, Chouaid C, Wolf M, Vinolas N, Soldatenkova V, Ripoche V, Nguyen T, Visseren-Grul C. A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer. Lung Cancer. 2015;90(3):397-404.
  44. Scherpereel A, Fernandes J, Cotté F, Blein C, Debieuvre D, Durand-Zaleski I, Gaudin A, Ozan N, Saitta B, Souquet P, Vainchtock A, Westeel V, Chouaid C. Access to Innovative Drugs in Patients with Metastatic Lung Cancer in French Public Hospitals (the Territoire Study). Value Health. 2015;18(7):A341.
  45. Salomon L, Bastuji-Garin S, Soulie M, Devonec M, Boutin E, Mandron E, Benoit G, Rischmann P, Mottet N, Gasman D, Irani J, De la Taille A, Zerbib M, Vaesen C, Dore B, Lebret T, Colombel M, Lechevallier E, Gregoire L, Allory Y, Abbou C. [Not Available]. Prog Urol. 2015;25(13):793.
  46. Salomon L, Bastuji-Garin S, Mazerolles C, Devonec M, Soulie M, Benoit G, Rischmann P, Decaussin-Petrucci M, Mottet N, Gasman D, Fromont-Hankard G, Irani J, De la Taille A, Zerbib M, Ferlicot S, Comperat E, Vaesen C, Beuvon F, Lebret T, Boutin E, Mege-Lechevallier F, Dore B, Radulescu C, Paoletti M, Shar A, Colombel M, Lechevallier E. [Not Available]. Prog Urol. 2015;25(13):792-3.
  47. Rwabihama J-P, Rabus M-T, Perilliat J-G. [Evolution of patients' rights at the end of life]. Presse Med. 2015;44(4 Pt 1):392-400.
  48. Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet P-J, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 2015;16(3):257-65.
  49. Revel M-P, Fitton I, Audureau E, Benzakoun J, Lederlin M, Chabi M-L, Rousset P. Breast dose reduction options during thoracic CT: influence of breast thickness. AJR Am J Roentgenol. 2015;204(4):W421-8.

2014

  1. Fromantin I, Watson S, Baffie A, Rivat A, Falcou M-C, Kriegel I, Ingenior Yde Rycke. A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. Ostomy Wound Manage. 2014;60(6):38-48.
  2. Amiot A, Mansour H, Baumgaertner I, Delchier J-C, Tournigand C, Furet J-P, Carrau J-P, Canoui-Poitrine F, Sobhani I. The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening. PLoS One. 2014;9(7):e99233.
  3. Chouaid C, Dujon C, Do P, Monnet I, Madroszyk A, Le Caer H, Auliac JBernard, Bérard H, Thomas P, Lena H, Robinet G, Baize N, Bizieux-Thaminy A, Fraboulet G, Locher C, Le Treut J, Hominal S, Vergnenègre A. Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01). Lung Cancer. 2014;86(2):170-3.
  4. Chauvin A, Le Thuaut A, Belhassan M, Le Baleur Y, Mesli F, Bastuji-Garin S, Delchier JCharles, Amiot A. Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study. Dig Liver Dis. 2014;46(8):695-700.
  5. Canoui-Poitrine F, Veerabudun K, Larmignat P, Letournel M, Bastuji-Garin S, Richalet J-P. Risk prediction score for severe high altitude illness: a cohort study. PLoS One. 2014;9(7):e100642.
  6. Canoui-Poitrine F, Poulain C, Molto A, Le Thuaut A, Lafon C, Farrenq V, Ferkal S, Le Corvoisier P, Ghaleh B, Bastuji-Garin S, Fautrel B, Dougados M, Claudepierre P. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort. Arthritis Care Res (Hoboken). 2014;66(9):1395-402.
  7. Caillet P, Mongiat-Artus P, Liuu E, Dutendas S, Paillaud E. [Kidney and bladder cancers in the elderly]. Soins Gerontol. 2014;(109):38-42.
  8. Bütow Z, Audureau E, Salomon L, De la Taille A, Yiou R. [Not Available]. Prog Urol. 2014;24(13):890.
  9. Bories P-N, Laurent M, Liuu E, Denjean L, Popovici T, Paillaud E. Interleukin-10 promoter (-1082) polymorphism in association with repeated hospital-acquired infections in elderly patients. Aging Clin Exp Res. 2014;26(1):25-31.
  10. Borget I, Perol M, Pérol D, Lavole A, Greillier L, Do P, Westeel V, Crequit J, Lena H, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Chabaud S, Vergnenègre A, Zalcman G, Chouaid C. Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study. BMC Cancer. 2014;14:953.
  11. Berrut G, Dibon C, Hanon O, Gavazzi G, Chassagne P, de Decker L. [Care of elderly subject with iron deficiency anaemia: evaluation of geriatric practice]. Geriatr Psychol Neuropsychiatr Vieil. 2014;12 Suppl 2:17-24.
  12. Ghebriou D, Avenin D, Caillet P, Mongiat-Artus P, Durdux C, Massard C, Culine S. [FRancilian Oncogeriatric Group (FROG)'s focus on management of elderly patients with bladder cancer]. Bull Cancer. 2014;101(9):841-55.
  13. Belkacemi Y, Bigorie V, Pan Q, Bouaita R, Pigneur F, Itti E, Badaoui H, Assaf E, Caillet P, Calitchi E, Bosc R. Breast radiotherapy (RT) using tangential fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement. Ann Surg Oncol. 2014;21(12):3758-65.
  14. Gauvain C, Crequit P, Rousseau-Bussac G, Ganoun A, Baud M, Chouaid C. [Adjuvant chemotherapy of non-small cell lung cancer: Tolerance of combined cisplatin-pemetrexed therapy]. Rev Mal Respir. 2014;31(9):817-21.
  15. Barlesi F, Scherpereel A, Gorbunova V, Gervais R, Vikström A, Chouaid C, Chella A, Kim JH, Ahn MJ, Reck M, Pazzola A, Kim HT, Aerts JG, Morando C, Loundou A, Groen HJM, Rittmeyer A. Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial. Ann Oncol. 2014;25(5):1044-52.
  16. Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res. 2014;27(1):134-9.
  17. Auliac JB, Chouaid C, Greillier L, Greiller L, Monnet I, Le Caer H, Falchero L, Corre R, Descourt R, Bota S, Berard H, Schott R, Bizieux A, Fournel P, Labrunie A, Marin B, Vergnenegre A. Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study. Lung Cancer. 2014;85(3):415-9.
  18. Pallud J, Audureau E, Blonski M, Sanai N, Bauchet L, Fontaine D, Mandonnet E, Dezamis E, Psimaras D, Guyotat J, Peruzzi P, Page P, Gal B, Parraga E, Baron M-H, Vlaicu M, Guillevin R, Devaux B, Duffau H, Taillandier L, Capelle L, Huberfeld G. Epileptic seizures in diffuse low-grade gliomas in adults. Brain. 2014;137(Pt 2):449-62.
  19. Oubaya N, Mahmoudi R, Jolly D, Zulfiqar AA, Quignard E, Cunin C, Nazeyrollas P, Novella JL, Dramé M. Screening for frailty in elderly subjects living at home: validation of the Modified Short Emergency Geriatric Assessment (SEGAm) instrument. J Nutr Health Aging. 2014;18(8):757-64.
  20. Moran T, Wei J, Cobo M, Qian X, Domine M, Zou Z, Bover I, Wang L, Provencio M, Yu L, Chaib I, You C, Massuti B, Song Y, Vergnenegre A, Lu H, Lopez-Vivanco G, Hu W, Robinet G, Yan J, Insa A, Xu X, Majem M, Chen X, R Peñas deLas, Karachaliou N, Sala MA, Wu Q, Isla D, Zhou Y, Baize N, Zhang F, Garde J, Germonpre P, Rauh S, ALHusaini H, Sanchez-Ronco M, Drozdowskyj A, Sanchez JJ, Camps C, Liu B, Rosell R. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies. Ann Oncol. 2014;25(11):2147-55.
  21. Mézière A, Audureau E, Vairelles S, Krypciak S, Dicko M, Monié M, Giraudier S. B12 deficiency increases with age in hospitalized patients: a study on 14,904 samples. J Gerontol A Biol Sci Med Sci. 2014;69(12):1576-85.
  22. Loustau V, Debouverie O, Canoui-Poitrine F, Baili L, Khellaf M, Touboul C, Languille L, Loustau M, Bierling P, Haddad B, Godeau B, Pourrat O, Michel M. Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol. 2014;166(6):929-35.
  23. Lerouge D, Rivière A, Dansin E, Chouaid C, Dujon C, Schott R, Lavole A, Le Pennec V, Fabre E, Crequit J, Martin F, Dehette S, Fournel P, Precheur-Agulhon B, Lartigau E, Zalcman G. A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer. BMC Cancer. 2014;14:231.
  24. Rousseau-Bussac G, Crequit P, Alifano M, Chouaid C. [Management of malignant pericardial effusion in lung cancer]. Rev Mal Respir. 2014;31(8):746-53.
  25. Lecomte F, Huet S, Audureau E, Guyerdet V, Pourriat J-L, Claessens Y-E. Patients in pain that refuse acetaminophen at triage. Am J Emerg Med. 2014;32(4):388-9.
  26. Laurent M, Paillaud E, Tournigand C, Caillet P, Le Thuaut A, Lagrange J-L, Beauchet O, Vincent H, Carvahlo-Verlinde M, Culine S, Bastuji-Garin S, Canoui-Poitrine F. Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study. Oncologist. 2014;19(3):275-82.
  27. Richalet J-P, Canoui-Poitrine F. Rebuttal to the con statement. High Alt Med Biol. 2014;15(3):321.
  28. Ladner J, Besson M-H, Rodrigues M, Audureau E, Saba J. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health. 2014;14:670.
  29. Postel-Vinay N, Hanon O, Clerson P, Brown JM, Ménard J, Paillaud E, Alonso E, Pasquier F, Pariel S, Belliard S, Péré J-J, Belmin J. Validation of the Test Your Memory (F-TYM Test) in a French memory clinic population. Clin Neuropsychol. 2014;28(6):994-1007.
  30. Grimaldi D, Canoui-Poitrine F, Croisille L, Lee K, Roudot-Thoraval F, Languille L, Khellaf M, Michel M, Godeau B, Bierling P. Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding. Ann Hematol. 2014;93(2):309-15.
  31. Ploussard G, Albrand G, Rozet F, Lang H, Paillaud E, Mongiat-Artus P. Challenging treatment decision-making in older urologic cancer patients. World J Urol. 2014;32(2):299-308.
  32. Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B, Adib-Conquy M, Cavaillon J-M. CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis. J Immunol. 2014;192(5):2449-59.
  33. Valipour A, Herth FJF, Burghuber OC, Criner G, Vergnon J-M, Goldin J, Sciurba F, Ernst A. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387-96.
  34. Simon D, Detournay B, Eschwege E, Bouée S, Bringer J, Attali C, Dejager S. Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study. Diabetes Ther. 2014;5(1):207-24.

2013

  1. Lafuente-Lafuente C, Paillaud E, Belmin J. [Prescribing drugs in the elderly: improvements are necessary]. Presse Med. 2013;42(2):168-70.
  2. E Colombo S, Hoffman I. Acute high-altitude illnesses. N Engl J Med. 2013;369(17):1665-6.
  3. Caillet P, Souberbielle JC, Jaglal SB, Reymondier A, Van Ganse E, Chapurlat R, Schott AM. Vitamin D supplementation in a healthy, middle-aged population: actual practices based on data from a French comprehensive regional health-care database. Eur J Clin Nutr. 2013;67(11):1133-7.
  4. Bernard E, Saint-Lary O, Haboubi L, Le Breton J. [Cervical cancer screening: women's knowledge and participation]. Sante Publique. 2013;25(3):255-62.
  5. Fromantin I, Seyer D, Watson S, Rollot F, Elard J, Escande MChristine, De Rycke Y, Kriegel I, Garde VLarreta. Bacterial floras and biofilms of malignant wounds associated with breast cancers. J Clin Microbiol. 2013;51(10):3368-73.
  6. Amigues I, Schott A-M, Amine M, Gelas-Dore B, Veerabudun K, Paillaud E, Beauchet O, Rolland Y, Poitrine FCanouï, Bonnefoy M. Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: the prospective EPIDOS study. J Am Med Dir Assoc. 2013;14(5):352-7.
  7. Chouaid C, Agulnik J, Goker E, Herder GJM, Lester JF, Vansteenkiste J, Finnern HW, Lungershausen J, Eriksson J, Kim K, Mitchell PLR. Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting. J Thorac Oncol. 2013;8(8):997-1003.
  8. Chouaid C. [Supportive care in thoracic oncology: a new series in the Revue]. Rev Mal Respir. 2013;30(2):97-8.
  9. Chaput U, Heresbach D, Audureau E, Vanbiervliet G, Gaudric M, Bichard P, Bauret P, Coumaros D, Ponchon T, Fumex F, Bensoussan E, Lamouliatte H, Chryssostalis A, Robin F, Prat F. Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study. United European Gastroenterol J. 2013;1(2):93-102.
  10. Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, Pouget F, Wolkenstein P, Bastuji-Garin S. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133(6):1506-11.
  11. Cambot M, Mazurier C, Canoui-Poitrine F, Hebert N, Picot J, Clay D, Picard V, Ripoche P, Douay L, Dubart-Kupperschmitt A, Cartron J-P. In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders. Am J Hematol. 2013;88(5):343-9.
  12. Bylicki O, Ferlay C, Chouaid C, Lavole A, Barlesi F, Dubos C, Westeel V, Crequit J, Corre R, Vergnenègre A, Monnet I, Le Caer H, Fournel P, Vaylet F, Falchero L, Poudenx M, Linard P, Pérol D, Zalcman G, Perol M. Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study. J Thorac Oncol. 2013;8(7):906-14.
  13. Bourgault M, Grimbert P, Verret C, Pourrat J, Herody M, Halimi JMichel, Karras A, Amoura Z, Jourde-Chiche N, Izzedine H, François H, Boffa J-J, Hummel A, Bernadet-Monrozies P, Fouque D, Canoui-Poitrine F, Lang P, Daugas E, Audard V. Acute renal infarction: a case series. Clin J Am Soc Nephrol. 2013;8(3):392-8.
  14. Bonnet-Zamponi D, d'Arailh L, Konrat C, Delpierre S, Lieberherr D, Lemaire A, Tubach F, Lacaille S, Legrain S. Drug-related readmissions to medical units of older adults discharged from acute geriatric units: results of the Optimization of Medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc. 2013;61(1):113-21.
  15. Blondiaux E, Pidial L, Vilar J, Autret G, Balvay D, Audureau E, Bruneval P, Bel A, Cuenod C-A, Silvestre J-S, Clément O. Evaluation of rat heart microvasculature with high-spatial-resolution susceptibility-weighted MR imaging. Radiology. 2013;269(1):277-82.
  16. Blachier M, Coutanceau B, Dougados M, Saraux A, Bastuji-Garin S, Ferkal S, Le Corvoisier P, Farrenq V, Poulain C, Ghaleh B, Canoui-Poitrine F, Claudepierre P. Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort. Ann Rheum Dis. 2013;72(6):979-85.
  17. Fauque P, Audureau E, Leandri R, Delaroche L, Assouline S, Epelboin S, Jouannet P, Patrat C. Is the nuclear status of an embryo an independent factor to predict its ability to develop to term?. Fertil Steril. 2013;99(5):1299-1304.e3.
  18. Blachier M, Canoui-Poitrine F, Dougados M, LeThuaut A, Fautrel B, Ferkal S, Le Corvoisier P, Farrenq V, Poulain C, Ghaleh B, Bastuji-Garin S, Claudepierre P. Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort. Rheumatology (Oxford). 2013;52(9):1686-93.
  19. Doz M, Chouaid C, Com-Ruelle L, Calvo E, Brosa M, Robert J, Decuypère L, Pribil C, Huerta A, Detournay B. The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med. 2013;13:15.
  20. Belkacemi Y, Allab-Pan Q, Bigorie V, Khodari W, Beaussart P, Totobenazara J-L, Mège J-P, Caillet P, Pigneur F, Dao T-H, Salmon R, Calitchi E, Bosc R. The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area. Ann Oncol. 2013;24(8):2023-8.
  21. Dicko M, Caillet P, Lafuente-Lafuente C, Paillaud E. [Iatrogenic agitation in elderly patient: prevalence, aetiologies and management]. Presse Med. 2013;42(2):181-6.
  22. Baud M, Strano S, Dechartres A, Jouni R, Triponez F, Chouaid C, Forgez P, Damotte D, Roche N, Régnard J-F, Alifano M. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis. J Thorac Cardiovasc Surg. 2013;145(5):1305-11.
  23. Decroisette C, Galerneau L-M, Hominal S, Chouaid C. [Epidemiology, management and cost of bone metastases from lung cancer]. Rev Mal Respir. 2013;30(4):309-15.
  24. Chouaid C, Le Caer H, Corre R, Crequit J, Locher C, Falchero L, Dujon C, Bérard H, Monnet I, Vergnenègre A. Cost analysis of erlotinib versus chemotherapy for first-line treatment of non-small-cell lung cancer in frail elderly patients participating in a prospective phase 2 study (GFPC 0505). Clin Lung Cancer. 2013;14(2):103-7.
  25. La Combe B, Gaillard S, Bennis S, Chouaid C. [Management of spinal metastases of lung cancer]. Rev Mal Respir. 2013;30(6):480-9.
  26. Krypciak S, Mézière A, Belmin J, Herbaud S, Paillaud E. [Which vaccination and cardiovascular prevention in elderly?]. Presse Med. 2013;42(2):202-8.
  27. Guedj M, Saad A, Audureau E, Gatinel D. Photorefractive keratectomy in patients with suspected keratoconus: five-year follow-up. J Cataract Refract Surg. 2013;39(1):66-73.
  28. Grandfils N, Detournay B, Attali C, Joly D, Simon D, Vergès B, Toussi M, Briand Y, Delaitre O. Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in france: a cross-sectional study. Int J Endocrinol. 2013;2013:640632.
  29. Mézière A, Paillaud E, Plaud B. [Anesthesia in the elderly]. Presse Med. 2013;42(2):197-201.
  30. Gellen B, Lesault P-F, Canoui-Poitrine F, Champagne S, Mouillet G, Pongas D, Le Thuaut A, Jakljevic T, Boudiche S, de la Vega M, Maalej A, Veugeois A, Dubois-Randé J-L, Teiger E. Feasibility limits of transradial primary percutaneous coronary intervention in acute myocardial infarction in the real life (TRAP-AMI). Int J Cardiol. 2013;168(2):1056-61.
  31. Mézière A, Paillaud E, Belmin J, Pariel S, Herbaud S, Canoui-Poitrine F, Le Thuaut A, Marty J, Plaud B. Delirium in older people after proximal femoral fracture repair: role of a preoperative screening cognitive test. Ann Fr Anesth Reanim. 2013;32(9):e91-6.
  32. Gellen B, Canoui-Poitrine F, Lesault P-F, Le Thuaut A, Lim P, Gueret P, Guendouz S, Pongas D, Teiger E, Dubois-Randé J-L, Hittinger L, Damy T. Usefulness of tissue Doppler imaging for assessing left ventricular filling pressure in patients with stable severe systolic heart failure. Am J Cardiol. 2013;112(10):1619-24.
  33. Mézière A, Blachier M, Thomas S, Verny M, Herbaud S, Bouillanne O, Henry O, David J-P, Le Thuaut A, Canoui-Poitrine F, Paillaud E. Neuropsychiatric symptoms in elderly inpatients: a multicenter cross-sectional study. Dement Geriatr Cogn Dis Extra. 2013;3(1):123-30.
  34. Ferrat E, Le Breton J, Veerabudun K, Bercier S, Brixi Z, Khoshnood B, Paillaud E, Attali C, Bastuji-Garin S. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer. 2013;109(6):1437-44.
  35. Mazières J, Peters S, Lepage B, Cortot AB, Barlesi F, Beau-Faller M, Besse B, Blons H, Mansuet-Lupo A, Urban T, Moro-Sibilot D, Dansin E, Chouaid C, Wislez M, Diebold J, Felip E, Rouquette I, Milia JD, Gautschi O. Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives. J Clin Oncol. 2013;31(16):1997-2003.
  36. Leveziel N, Caillaux V, Bastuji-Garin S, Zmuda M, Souied EH. Angiographic and optical coherence tomography characteristics of recent myopic choroidal neovascularization. Am J Ophthalmol. 2013;155(5):913-9.
  37. Lester JF, Agulnik J, Akerborg O, Chouaid C, De Geer A, Finnern HW, Herder GJM, Lungershausen J, Mitchell PLR, Vansteenkiste J, Ziske C, Goker E. What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study. Lung Cancer. 2013;82(1):128-35.
  38. Le Treut J, Sault MC, Lena H, Souquet PJ, Vergnenegre A, Le Caer H, Berard H, Boffa S, Monnet I, Damotte D, Chouaid C. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Ann Oncol. 2013;24(6):1548-52.
  39. Le Corvoisier P, Renard V, Roudot-Thoraval F, Cazalens T, Veerabudun K, Canoui-Poitrine F, Montagne O, Attali C. Long-term effects of an educational seminar on antibiotic prescribing by GPs: a randomised controlled trial. Br J Gen Pract. 2013;63(612):e455-64.
  40. Lafuente-Lafuente C, Baudry E, Paillaud E, Piette F. [Clinical pharmacology and aging]. Presse Med. 2013;42(2):171-80.
  41. Ladner J, Tekinturhan E, Tavolacci M-P, Audureau E, Saba J. Increasing access to care for chronic myeloid leukemia patients: assessment of a scaling-up program. J Health Care Poor Underserved. 2013;24(4):1486-97.
  42. Zehou O, Bularca S, Bastuji-Garin S, Ortonne N, Valeyrie-Allanore L, Wolkenstein P, Duong TA. Neurofibromatosis 1 phenotype associated to malignant peripheral nerve sheath tumours: a case-control study. J Eur Acad Dermatol Venereol. 2013;27(8):1044-7.
  43. Perol M, Pérol D, Chouaid C. Reply to N. Singh et al. J Clin Oncol. 2013;31(9):1251-2.
  44. Vergnenègre A, Hominal S, Tchalla AEdem, Bérard H, Monnet I, Fraboulet G, Baize N, Audigier-Valette C, Robinet G, Oliviero G, Le Caer H, Thomas P, Gérinière L, Mastroianni B, Chouaid C. Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study). Lung Cancer. 2013;82(2):353-7.
  45. Pautas C, Sbidian E, Hicheri Y, Bastuji-Garin S, Bretagne S, Corbel C, Gregoire L, Maury S, Merabet L, Cordonnier C, Cambau E. A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter. J Antimicrob Chemother. 2013;68(4):943-6.
  46. Vergnenegre A, Borget I, Chouaid C. Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents. Clinicoecon Outcomes Res. 2013;5:137-41.
  47. Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, Bauchet L, Peruzzi P, Frénay M, Colin P, Guillevin R, Bernier V, Baron M-H, Guyotat J, Duffau H, Taillandier L, Capelle L. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol. 2013;15(5):595-606.
  48. Vergnenègre A, Borget I, Chouaid C. Treatment of lung cancer: will financial issues become a criterion of choice?. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):273-5.
  49. Paleiron N, André M, Grassin F, Chouaid C, Venissac N, Margery J, Couturaud F, Noël-Savina E, Tromeur C, Vinsonneau U, Vedrine L, Leroyer C, Nowak E, Berard H, Thomas P, Brouchet L, Bagan P, Fournel P, Mottier D, Robinet G. [Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]. Rev Mal Respir. 2013;30(3):231-7.
  50. Valeyrie-Allanore L, Bastuji-Garin S, Guégan S, Ortonne N, Bagot M, Roujeau J-C, Revuz JE, Wechsler J, Wolkenstein P. Prognostic value of histologic features of toxic epidermal necrolysis. J Am Acad Dermatol. 2013;68(2):e29-35.
  51. Thibault V, Gaudy-Graffin C, Colson P, Gozlan J, Schnepf N, Trimoulet P, Pallier C, Saune K, Branger M, Coste M, Thoraval FRoudot. Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study. Virol J. 2013;10:87.
  52. Scagliotti GV, Felip E, Besse B, von Pawel J, Mellemgaard A, Reck M, Bosquee L, Chouaid C, Lianes-Barragán P, Paul EM, Ruiz-Soto R, Sigal E, Ottesen LH, Lechevalier T. An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer. J Thorac Oncol. 2013;8(12):1529-37.
  53. Rousset P, Chaillot P-F, Audureau E, Rey-Salmon C, Becour B, Fitton I, Vadrot D, Revel M-P. Detection of residual packets in cocaine body packers: low accuracy of abdominal radiography-a prospective study. Eur Radiol. 2013;23(8):2146-55.
  54. Rittmeyer A, Gorbunova V, Vikström A, Scherpereel A, Kim J-H, Ahn M-J, Chella A, Chouaid C, Campbell AK, Barlesi F. Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089). J Thorac Oncol. 2013;8(11):1409-16.
  55. Richalet J-P, Canoui-Poitrine F, Canoui-Poitrine F, Larmignat P. Acute high-altitude illnesses. N Engl J Med. 2013;369(17):1664-5.
  56. Ramalingam S, Crawford J, Chang A, Manegold C, Perez-Soler R, Douillard J-Y, Thatcher N, Barlesi F, Owonikoko T, Wang Y, Pultar P, Zhu J, Malik R, Giaccone G. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial). Ann Oncol. 2013;24(11):2875-80.

2011

  1. Cottu PH, Fourchotte V, Vincent-Salomon A, Kriegel I, Fromantin I. Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy. J Wound Care. 2011;20(9):403-4, 406, 408 passim.

2006

  1. Rwabihama J-P, Aubourg R, Oliary J, Mouly S, Champion K, Leverge R, Bergmann J-F. [Use and misuse of intravenous drug administration in a department of internal medicine]. Presse Med. 2006;35(10 Pt 1):1453-60.